Seong Gong Je, Rho Sae Heun, Kim Chang Sik, Moon Jong Il, Kook Michael Scott, Kim Yong Yeon, Ma Kyoung Tak, Hong Young Jae, Nelson Lindsay A, Kruft Bonnie, Stewart Jeanette A, Stewart William C
Yonsei University, Seoul, Korea.
J Ocul Pharmacol Ther. 2009 Feb;25(1):91-6. doi: 10.1089/jop.2008.0056.
The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normal tension glaucoma (NTG) Asian adult patients in South Korea.
This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg.
Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs <or=14 mmHg (21/93), 23% progressed and >or=15 mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 +/- 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 +/- 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 +/- 2.2 mmHg in the stable group and 17.8 +/- 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP.
This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.
本研究旨在评估降低眼压对韩国正常眼压性青光眼(NTG)成年亚洲患者的潜在益处。
这是一项对韩国166例NTG成年亚洲患者的回顾性多中心分析。患者群体包括有至少5年可用于评估记录的韩国NTG患者。所有患者均有典型的青光眼性视盘和/或视野改变,但眼压从未记录超过21 mmHg。
总体而言,在随访期间,48例(29%)患者病情进展,116例(71%)患者病情稳定。眼压≤14 mmHg的患者(21/93)中,23%病情进展;眼压≥15 mmHg的患者(27/73)中,37%病情进展(P = 0.041)。稳定组的平均眼压为14.0±1.8 mmHg,而进展组的平均眼压为14.4±1.6 mmHg(P = 0.20)。稳定组的平均最高眼压为17.4±2.2 mmHg,进展组为17.8±2.0 mmHg(P = 0.26)。多变量线性回归分析未发现任何病情进展的独立危险因素,包括年龄、性别或平均眼压和最高眼压。
本研究提供了初步证据,表明接受治疗以降低眼压的韩国正常眼压性青光眼患者在5年期间病情进展的发生率可能低于眼压较高的患者。需要更多研究来证实这一发现。